Servier Slovakia

At Servier, we draw strength from our independence. We believe being free to make our own decisions and adopt a long-term vision enables us to fulfill our vocation as a Group committed to therapeutic progress to serve patient needs. It makes us unique in the pharmaceutical industry. „Servier’s governance model headed by a non-profit foundation aligns perfectly with the long-term perspective required for research and development. Our independence from market forces means we can invest heavily in R&D to innovate and develop new medicines. Servier invests over 20% of revenue from brand-name medicines in R&D each year.“ Day in, day out, we capitalize on the talent and engagement of the 21,400 people employed throughout our Group in order to make our brand-name and generic medicines available to patients in over 150 countries. These medicines are the fruit of our knowledge and expertise in our therapeutic areas of oncology, neuroscience, immuno-inflammation, cardiovascular diseases and metabolism. If you wish to contact us, to report an adverse reaction, product quality complaint or suspected falsified product, or you have any other question or suggestion that you would like to share, please visit